billable test

billable test

A unit of productivity in clinics and hospitals (where it is an “ordered” lab test).

billable test

Lab medicine A unit of productivity in clinics and hospitals–where it is an 'ordered' laboratory test. Cf Workload unit.
Mentioned in ?
References in periodicals archive ?
For the 6 rate monitors, subscribers simultaneously tracked the opportunities for the events' potential occurrence: outpatient test orders entered into a laboratory computer system, patients presenting to be identified for specimen collection, blood specimens collected, STAT test specimens processed, critical value reporting events attempted, and--as a surrogate unit for reports issued--units of 10 000 billable test results.
Studies have reported error rate metrics as errors per sample, (3) per analyses, (4) per requisition (5) and per billable test.
Distributions Relating to the Number of Tests Offered on the Test Menu and Billable Test Volume (N = 50) Percentile 10th 25th 50th 75th 90th No.
Prior to 1997, billable test counts were used for counting tests.
The billable test (BT) is most often used as the unit of service (UOS) when calculating the productivity levels.
The Workload Reporting System has been replaced by CAP's Laboratory Management Index Program, or LMIP, which uses standardized billable test counts.
I contend that on a daily basis, applying worked hours per billable test is nothing more than a rough estimate of lab productivity, which should not be judged by any single day's "worked hours per unit.
There are two costs you should obtain: cost per reportable test and cost per billable test.
We experienced a significant improvement in our billable test per FTE (Figure 3).
For example, instead of buying equipment, reagents, disposables, and service, labs can contract for these items on a results basis, such as the cost per billable test.
Determine billable test frequencies Laboratory information system (LIS) Decision support system (DSS) 2.
7 October 2014 - US molecular diagnostics company CombiMatrix Corp (NASDAQ:CBMX) said Tuesday it anticipates its total microarray testing volumes for the third quarter of 2014 to rise by 24% year-on-year to 1,420 billable tests performed.